These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 26950376)
21. Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data. Duarte RF; Shaw BE; Marín P; Kottaridis P; Ortiz M; Morante C; Delgado J; Gayoso J; Goterriz R; Martínez-Chamorro C; Mateos-Mazón JJ; Ramírez C; de la Rubia J; Achtereekte H; Gandhi PJ; Douglas KW; Russell NH Bone Marrow Transplant; 2011 Jan; 46(1):52-8. PubMed ID: 20305700 [TBL] [Abstract][Full Text] [Related]
22. The Prognostic Significance of Pretransplant Plasma Fibrinogen Levels in Autologous Hematopoietic Stem Cell Transplantation. Ogura S; Nakazato T Transplant Proc; 2021; 53(1):405-407. PubMed ID: 32505504 [TBL] [Abstract][Full Text] [Related]
23. Effectiveness and cost analysis of "just-in-time" salvage plerixafor administration in autologous transplant patients with poor stem cell mobilization kinetics. Li J; Hamilton E; Vaughn L; Graiser M; Renfroe H; Lechowicz MJ; Langston A; Prichard JM; Anderson D; Gleason C; Lonial S; Flowers CR; Kaufman JL; Waller EK Transfusion; 2011 Oct; 51(10):2175-82. PubMed ID: 21492180 [TBL] [Abstract][Full Text] [Related]
24. Impact of the Conditioning Regimen Dose Intensity Before Autologous Stem Cell Transplantation on the Pulmonary Function Test Abnormalities in Patients With Lymphoma and Multiple Myeloma: Single Center Experience. Bou Akl I; Matar M; Khalil PB; Massoud R; Ghaoui N; Karout L; Zahreddine A; Bazarbachi A; El-Cheikh J Clin Lymphoma Myeloma Leuk; 2020 Jun; 20(6):371-376.e1. PubMed ID: 32151585 [TBL] [Abstract][Full Text] [Related]
25. Outcome for patients with leukemia, multiple myeloma and lymphoma who relapse after high dose therapy and autologous stem cell support. Johnsen HE; Björkstrand B; Carlson K; Gruber A; Blystad A; Fast A; Boesen AM; Björkholm M; Sallerfors B; Ruutu T; Carneskog J; Malm A; Geisler C; Lehtinen M; Schrøder H; Brinch L; Remes K; Tidefelt U; Heilmann C; Hörnsten P; Thorling K; Daugaard G Leuk Lymphoma; 1996 Dec; 24(1-2):81-91. PubMed ID: 9049964 [TBL] [Abstract][Full Text] [Related]
26. In-hospital complications of autologous hematopoietic stem cell transplantation for lymphoid malignancies: clinical and economic outcomes from the Nationwide Inpatient Sample. Jones JA; Qazilbash MH; Shih YC; Cantor SB; Cooksley CD; Elting LS Cancer; 2008 Mar; 112(5):1096-105. PubMed ID: 18286506 [TBL] [Abstract][Full Text] [Related]
27. A Japanese single-hospital observational trial with a retrospective case-control analysis of varicella zoster virus reactivation after autologous peripheral blood stem cell transplantation. Mawatari M; Isoda A; Miyazawa Y; Sawamura M; Matsumoto M Transpl Infect Dis; 2015 Aug; 17(4):544-50. PubMed ID: 26041667 [TBL] [Abstract][Full Text] [Related]
28. Hepatitis B virus reactivation in patients with multiple myeloma receiving bortezomib-containing regimens followed by autologous stem cell transplant. Li J; Huang B; Li Y; Zheng D; Zhou Z; Liu J Leuk Lymphoma; 2015 Jun; 56(6):1710-7. PubMed ID: 25098429 [TBL] [Abstract][Full Text] [Related]
29. Incidence of Clostridium difficile-associated diarrhea before and after autologous peripheral blood stem cell transplantation for lymphoma and multiple myeloma. Arango JI; Restrepo A; Schneider DL; Callander NS; Ochoa-Bayona JL; Restrepo MI; Bradshaw P; Patterson J; Freytes CO Bone Marrow Transplant; 2006 Mar; 37(5):517-21. PubMed ID: 16435018 [TBL] [Abstract][Full Text] [Related]
30. Absolute lymphocyte count as predictor of overall survival for patients with multiple myeloma treated with single autologous stem cell transplant. Jimenez-Zepeda VH; Reece DE; Trudel S; Chen C; Franke N; Winter A; Tiedemann R; Kukreti V Leuk Lymphoma; 2015; 56(9):2668-73. PubMed ID: 25573201 [TBL] [Abstract][Full Text] [Related]
31. Patient cytomegalovirus seropositivity with or without reactivation is the most important prognostic factor for survival and treatment-related mortality in stem cell transplantation from unrelated donors using pretransplant in vivo T-cell depletion with anti-thymocyte globulin. Kröger N; Zabelina T; Krüger W; Renges H; Stute N; Schrum J; Kabisch H; Schafhausen P; Jaburg N; Löliger C; Schäfer P; Hinke A; Zander AR Br J Haematol; 2001 Jun; 113(4):1060-71. PubMed ID: 11442503 [TBL] [Abstract][Full Text] [Related]
32. Autologous hematopoietic cell transplantation: an update for clinicians. Hamadani M Ann Med; 2014 Dec; 46(8):619-32. PubMed ID: 25211470 [TBL] [Abstract][Full Text] [Related]
33. Plerixafor added to chemotherapy plus G-CSF is safe and allows adequate PBSC collection in predicted poor mobilizer patients with multiple myeloma or lymphoma. Attolico I; Pavone V; Ostuni A; Rossini B; Musso M; Crescimanno A; Martino M; Iacopino P; Milone G; Tedeschi P; Coluzzi S; Nuccorini R; Pascale S; Di Nardo E; Olivieri A Biol Blood Marrow Transplant; 2012 Feb; 18(2):241-9. PubMed ID: 21791194 [TBL] [Abstract][Full Text] [Related]
34. High-dose chemotherapy and autologous CD34-positive blood stem cell transplantation for multiple myeloma in an HIV carrier. Kentos A; Vekemans M; Van Vooren JP; Lambermont M; Liesnard C; Feremans W; Farber CM Bone Marrow Transplant; 2002 Feb; 29(3):273-5. PubMed ID: 11859402 [TBL] [Abstract][Full Text] [Related]
35. Prediction of infectious events by the high-sensitivity C-reactive protein level before autologous hematopoietic cell transplantation for lymphoma and multiple myeloma. Sato M; Nakasone H; Wada H; Yamasaki R; Ishihara Y; Sakamoto K; Kawamura K; Ashizawa M; Machishima T; Terasako K; Kimura SI; Kikuchi M; Tanihara A; Yamazaki R; Tanaka Y; Kanda J; Kako S; Nishida J; Kanda Y Transpl Infect Dis; 2013 Aug; 15(4):E169-71. PubMed ID: 23782409 [No Abstract] [Full Text] [Related]
36. Autologous stem cell transplantation in elderly multiple myeloma patients aged ≥65 years: a two-centre Australian experience. Er J; Routledge D; Hempton J; Wood C; Joyce T; Harrison S; Campbell P Intern Med J; 2021 Feb; 51(2):280-283. PubMed ID: 33631863 [TBL] [Abstract][Full Text] [Related]
37. Autologous blood and marrow transplantation in patients 60 years and older. Leger CS; Bredeson C; Kearns B; Bence-Bruckler I; Atkins H; Huebsch L Biol Blood Marrow Transplant; 2000; 6(2A):204-10. PubMed ID: 10816029 [TBL] [Abstract][Full Text] [Related]